• 
  Lisa Alborghetti, Roberta Castriconi, Carlos Sosa-Marrero, Alessia Tudda, Maria Giulia Ubeira-Gabellini, et al.. Selective sparing of bladder and rectum sub-regions in radiotherapy of prostate cancer combining knowledge-based automatic planning and multicriteria optimization. Physics and Imaging in Radiation Oncology, 2023, 28, pp.100488. ⟨10.1016/j.phro.2023.100488⟩. ⟨hal-04225836⟩
• 
  Emeric Boisteau, Laetitia Dahan, Nicolas Williet, Karine Le Malicot, Jérôme Desramé, et al.. Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer. Oncologist, 2024, pp.oyae079. ⟨10.1093/oncolo/oyae079⟩. ⟨hal-04576050⟩
• 
  Morgane Gronnier, Kaies Hedhli, Chloé Sauzay, Valéry Salle, Pierre Duhaut, et al.. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers. BMC Cancer, 2024, 24 (1), pp.468. ⟨10.1186/s12885-024-12201-0⟩. ⟨hal-04552118⟩
• 
  Lionel Perrier, Frederic Balusson, Magali Morelle, Joël Castelli, Juliette Thariat, et al.. Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial. Radiotherapy & Oncology, 2024, Radiotherapy and Oncology : Journal of the European Society For Therapeutic, 193, pp.110116. ⟨10.1016/j.radonc.2024.110116⟩. ⟨hal-04444231⟩
• 
  Roxane Machavoine, Sylvie Helfre, Valérie Bernier, Stéphanie Bolle, Julie Leseur, et al.. Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French Experience.. Frontiers in Pediatrics, 2022, Frontiers in Pediatrics, 9, pp.783754. ⟨10.3389/fped.2021.783754⟩. ⟨hal-04572907⟩
• 
  Thierry André, David Tougeron, Guillaume Piessen, Christelle de La Fouchardière, Christophe Louvet, et al.. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. Journal of Clinical Oncology, 2023, 41 (2), pp.255-265. ⟨10.1200/JCO.22.00686⟩. ⟨hal-03975142⟩
• 
  Capucine Baldini, E. Charton, E. Schultz, L. Auroy, A. Italiano, et al.. Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study. ESMO Open, 2022, European Society for Medical Oncology, 7, pp.100468. ⟨10.1016/j.esmoop.2022.100468⟩. ⟨hal-04567217⟩
• 
  Karim Benali, Paul C. Zei, Michael Lloyd, Josef Kautzner, Charles Guenancia, et al.. One-Year Mortality and Causes of Death after Stereotactic Radiation Therapy for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis. Trends in Cardiovascular Medicine, 2024, Trends in Cardiovascular Medicine, ⟨10.1016/j.tcm.2023.12.008⟩. ⟨hal-04429271⟩
• 
  Anne Sophie Alix-Doucet, Constant Vinatier, Loic Fin, Hervé Léna, Hélène Rangé, et al.. Reporting of interventional clinical trial results in an academic center: a survey of completed studies. BMC Medical Research Methodology, 2024, 24 (1), ⟨10.1186/s12874-024-02221-6⟩. ⟨hal-04564442⟩
• 
  Corentin Louis. Les ARN circulaires régulés par le TGFβ dans le cholangiocarcinome intrahépatique : mécanismes et biomarqueurs. Médecine humaine et pathologie. Université de Rennes, 2023. Français. ⟨NNT : 2023URENB012⟩. ⟨tel-04561093⟩
• 
  Antoine Verger, T. Horowitz, F. Le Jeune, C. Prunier-Aesh, S. Querellou, et al.. Clinical authorization of amyloid PET in France: Towards a more precise diagnosis of Alzheimer's disease. Médecine Nucléaire - Imagerie Fonctionnelle et Métabolique, 2023, 47 (4), pp.175-178. ⟨10.1016/j.mednuc.2023.03.002⟩. ⟨hal-04415555⟩
• 
  Rose-Marie Fraboulet, Yanis Si Ahmed, Marc Aubry, Sébastien Corre, Marie-Dominique Galibert, et al.. Cirscan: a shiny application to identify differentially active sponge mechanisms and visualize circRNA-miRNA-mRNA networks. BMC Bioinformatics, 2024, 25 (1), pp.53. ⟨10.1186/s12859-024-05668-y⟩. ⟨hal-04540383⟩
• 
  Simon Le Goupil, Hadrien Laprade, Marc Aubry, Eric Chevet. Exploring the IRE1 interactome: from canonical signaling functions to unexpected roles. Journal of Biological Chemistry, 2024, 300 (4), pp.107169. ⟨10.1016/j.jbc.2024.107169⟩. ⟨hal-04540346⟩
• 
  Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, Pierre Thirion, Matthew Nankivell, et al.. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. Journal of Clinical Oncology, 2023, 41 (28), pp.4535-4547. ⟨10.1200/JCO.22.02279⟩. ⟨hal-04250829⟩
• 
  Rocio I. R. Macias, Vincenzo Cardinale, Timothy J. Kendall, Matias A. Avila, Maria Guido, et al.. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut, 2022, 71 (8), pp.1669-1683. ⟨10.1136/gutjnl-2022-327099⟩. ⟨hal-03689563⟩
• 
  Xavier Palard-Novello, Denise Visser, Nelleke Tolboom, Charlotte L. C. Smith, Gerben Zwezerijnen, et al.. Validation of image-derived input function using a long axial field of view PET/CT scanner for two different tracers. EJNMMI Physics, 2024, 11 (1), pp.25. ⟨10.1186/s40658-024-00628-0⟩. ⟨hal-04526330⟩
• 
  Aurore Haffreingue, Julien Tourneur-Marsille, Louise Montalva, Dominique Berrebi, Eric Ogier-Denis, et al.. Intraperitoneal insufflation of carbon dioxide rescues intestinal damage in an experimental murin model of colitis. Journal of Pediatric Gastroenterology and Nutrition, 2024, 78 (1), pp.68-76. ⟨10.1002/jpn3.12048⟩. ⟨hal-04357945⟩
• 
  P. Sargos, J. Le Guevelou, J. Khalifa, L. Albiges, D. Azria, et al.. The role of radiation therapy for de novo metastatic bladder and renal cancers. Cancer/Radiothérapie, 2024, 28 (1), pp.56 - 65. ⟨10.1016/j.canrad.2023.02.004⟩. ⟨inserm-04517309⟩
• 
  Jennifer Le Guevelou, Paul Sargos, Ludovic Ferretti, Stephane Supiot, David Pasquier, et al.. Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review. European Urology Oncology, In press, S2588-9311 (23), pp.00163-3. ⟨10.1016/j.euo.2023.08.003⟩. ⟨inserm-04517271⟩
• 
  Stephen Chan, Martin Schuler, Yoon-Koo Kang, Chia-Jui Yen, Julien Edeline, et al.. A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors. Journal of experimental & clinical cancer research, 2022, 41 (1), pp.189. ⟨10.1186/s13046-022-02383-5⟩. ⟨hal-04510216⟩

688

727